ARTV vs REGN: Which Stock is Better?

Side-by-side comparison of Artiva Biotherapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ARTV

Artiva Biotherapeutics Inc

$10.80

REGN

Regeneron Pharmaceuticals Inc

$701.42

Key Metrics Comparison

MetricARTVREGNWinner
Market Cap$253.10M$74.13BREGN
P/E RatioN/A17.27REGN
EPS (TTM)$N/A$40.94REGN
Revenue Growth-1.0%0.2%REGN
Gross Margin0.0%44.6%REGN

Analyze ARTV

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARTV or REGN a better investment?

Comparing ARTV and REGN: Artiva Biotherapeutics Inc has a market cap of $253.10M while Regeneron Pharmaceuticals Inc has $74.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARTV and REGN?

ARTV (Artiva Biotherapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARTV or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARTV or REGN?

REGN has higher revenue growth at 0.2% vs -1.0% for ARTV.

Which company is more profitable: ARTV or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for ARTV.

Which is the larger company: ARTV or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $74.13B compared to $253.10M for ARTV.

Should I buy ARTV or REGN in 2026?

Both ARTV and REGN have investment merit. ARTV trades at $10.80 while REGN trades at $701.42. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARTV and REGN stock?

Key differences: Market Cap ($253.10M vs $74.13B), P/E Ratio (N/A vs 17.3x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons